Pro Share Advisors LLC Invitae Corp Transaction History

Pro Share Advisors LLC

$36.5 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $3,930 - $6,737	9,358 Added 27.41%	43,501 $27,000
Q3 2023 Nov 13, 2023	SELL	$0.6 - $1.53 $22 - $58	-38 Reduced 0.11%	34,143 $20,000
Q2 2023 Aug 10, 2023	BUY	$1.05 - $1.63 $5,754 - $8,932	5,480 Added 19.09%	34,181 $38,000
Q1 2023 May 11, 2023	SELL	$1.2 - $2.73 $3,393 - $7,720	-2,828 Reduced 8.97%	28,701 $38,000
Q4 2022 Feb 02, 2023	BUY	$1.71 - $3.61 $9,393 - $19,829	5,493 Added 21.1%	31,529 $58,000
Q3 2022 Nov 04, 2022	SELL	$1.9 - $8.63 $6,235 - $28,323	-3,282 Reduced 11.19%	26,036 $64,000
Q2 2022 Aug 01, 2022	SELL	$2.13 - $9.01 $27,709 - $117,211	-13,009 Reduced 30.73%	29,318 $71,000
Q1 2022 May 10, 2022	SELL	$6.28 - $15.59 $41,887 - $103,985	-6,670 Reduced 13.61%	42,327 $337,000
Q4 2021 Feb 08, 2022	BUY	$14.7 - $28.67 $273,081 - $532,602	18,577 Added 61.07%	48,997 $748,000
Q3 2021 Nov 12, 2021	SELL	$24.31 - $33.6 $524,342 - $724,718	-21,569 Reduced 41.49%	30,420 $865,000
Q2 2021 Aug 13, 2021	BUY	$26.09 - $40.4 $510,763 - $790,910	19,577 Added 60.4%	51,989 $1.75 Million
Q1 2021 May 14, 2021	BUY	$33.06 - $56.93 $226,064 - $389,287	6,838 Added 26.74%	32,412 $1.24 Million
Q4 2020 Feb 09, 2021	BUY	$39.09 - $57.4 $446,603 - $655,795	11,425 Added 80.75%	25,574 $1.07 Million
Q3 2020 Nov 13, 2020	SELL	$28.43 - $44.67 $43,753 - $68,747	-1,539 Reduced 9.81%	14,149 $613,000
Q2 2020 Aug 03, 2020	BUY	$11.71 - $30.29 $183,706 - $475,189	15,688 New	15,688 $475,000
Q1 2020 May 15, 2020	SELL	$7.64 - $27.5 $89,747 - $323,042	-11,747 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$15.02 - $20.57 $176,439 - $241,635	11,747 New	11,747 $189,000

Others Institutions Holding NVTA

# of Institutions

Shares Held

2.12M

Call Options Held

Put Options Held

View Full List

About Invitae Corp

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

More about NVTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account